Oncology
8 drugs are in development for Bladder Cancer.
- Companies
- 5
- Clinical trials
- 70
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Bladder Cancer pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
About this indication
Bladder Cancer context
Oncology·MeSH: Urinary Bladder Neoplasms (D001749)
Narrower concept of MeSH descriptor Urinary Bladder Neoplasms
Prevalence
61.0 / 100K
Incidence
18.0 / 100K/yr
Compare drugs
Frequently asked questions
How many drugs are in development for Bladder Cancer?
BioSniper tracks 8 drugs in development for Bladder Cancer across 5 companies.
How many clinical trials target Bladder Cancer?
There are 70 clinical trials targeting Bladder Cancer tracked by BioSniper.
What is the prevalence of Bladder Cancer?
The estimated prevalence of Bladder Cancer is approximately 61.0 per 100,000 population.